Clinical Trials
12 trialsNCT06930859 2026-05-22
ELEGANCE
Novartis
Recruiting
NCT06830720 2026-05-08
CAROLEEN
Novartis
Recruiting
NCT06075758 2026-05-06
A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer
Novartis
Completed
NCT06905301 2026-05-05
IMPULSE
Novartis
Recruiting
NCT04943497 2026-04-01
PROSPERITY
Novartis
Completed
NCT05697146 2026-03-16
RosaLEE
Novartis
Active not recruiting
NCT06797531 2026-02-04
NISLEESA
Novartis
Recruiting
NCT06148506 2025-12-05
ValerEE
Novartis
Active not recruiting
NCT06495164 2025-11-25
A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer
Pfizer
Active not recruiting
NCT07072013 2025-07-18
IRINA
Novartis
Completed
NCT05569187 2022-11-08
Ribociclib in Combination With Non-steroidal Aromatase Inhibitors in Patients With Advanced Breast Cancer
Novartis
Completed
NCT05153135 2021-12-21
Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 Inhibitors
Novartis
Completed